Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
2.360
+0.120 (5.36%)
At close: Aug 13, 2025, 4:00 PM
2.350
-0.010 (-0.42%)
After-hours: Aug 13, 2025, 4:00 PM EDT
Endeavor Group Holdings Market Cap
Apyx Medical has a market cap or net worth of $88.88 million as of August 13, 2025. Its market cap has increased by 95.83% in one year.
Market Cap
88.88M
Enterprise Value
98.65M
1-Year Change
95.83%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since May 1, 1992, Apyx Medical's market cap has increased from $2.73M to $88.88M, an increase of 3,156.08%. That is a compound annual growth rate of 11.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 88.88M | 49.43% |
| Dec 31, 2024 | 59.48M | -34.47% |
| Dec 29, 2023 | 90.77M | 12.11% |
| Dec 30, 2022 | 80.96M | -81.61% |
| Dec 31, 2021 | 440.29M | 78.41% |
| Dec 31, 2020 | 246.78M | -14.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |